[The fact about e-cigarettes and cardiovascular risk].

Il punto su sigarette elettroniche e rischio cardiovascolare.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 29 5 2023
pubmed: 25 5 2023
entrez: 25 5 2023
Statut: ppublish

Résumé

Electronic cigarettes (e-cigarettes) are battery-powered devices containing a liquid based on propylene glycol or vegetable glycerin. These compounds, when vaporized, act as a vehicle for nicotine, flavors, and other chemical components. These devices have been marketed without clear evidence of risks, long-term safety, and efficacy. Toxicological data show lower plasma concentrations of carbon monoxide and other cancer-inducing substances as compared to traditional smoking. However, several studies have highlighted an increase in sympathetic tone, vascular stiffness, and endothelial dysfunction, all factors associated with cardiovascular risk that, however, is largely inferior to the cardiovascular risk related to traditional smoking. Recent clinical studies have shown how the use of e-cigarettes, combined with adequate psychological support, can be effective in reducing traditional smoking but not nicotine addiction. New policy directives are focusing on the possibility to ban some deleterious products in favor of the use of low-nicotine devices able to promote smoking cessation and reducing the risk of addiction, especially in young people. The use of e-cigarettes among smokers might be promoted with the specific aim of facilitating smoke cessation, but non-smokers and adolescents should be warned against using such devices. Finally, particular attention should be paid to smokers so that the combined use of electronic and traditional cigarettes can be limited as much as possible.

Identifiants

pubmed: 37227206
doi: 10.1714/4041.40206
doi:

Substances chimiques

Nicotine 6M3C89ZY6R

Types de publication

English Abstract Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

466-474

Auteurs

Roberto Spoladore (R)

Divisione di Cardiologia, Ospedale Alessandro Manzoni, Lecco.

Francesca Daus (F)

Scuola di Specializzazione in Malattie dell'Apparato Cardiovascolare, Università degli Studi Milano-Bicocca, Milano.

Sara Pezzini (S)

Scuola di Specializzazione in Malattie dell'Apparato Cardiovascolare, Università degli Studi Milano-Bicocca, Milano.

Francesca Napoli (F)

Scuola di Specializzazione in Malattie dell'Apparato Cardiovascolare, Università degli Studi Milano-Bicocca, Milano.

Luigi Cante (L)

Unità di Cardiologia, Dipartimento di Scienze Mediche Traslazionali, Università della Campania "Luigi Vanvitelli", Napoli.

Stefano Savonitto (S)

Clinica San Martino, Malgrate (LC).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH